BIORQ — Biora Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $35.40m
- $0.00m
Biora Therapeutics Inc expected to post a loss of 59 cents a share - Earnings Preview
Brief: Biora Therapeutics Further Reduces Net Debt And Monetizes Legacy Asset
Brief: Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600
Natera owes Ravgen $57 million in genetic-testing case, Texas jury says
Brief: Biora Therapeutics Reports Initiation Of Phase 1 Clinical Study Of BT-600
Brief: Biora Therapeutics Files Prospectus On Offer And Resale Of Up To 71.1 mln Shares
Brief: Biora Therapeutics Announces New Patent For Its Navicap™ Targeted Oral Delivery Platform
U.S. STOCKS ON THE MOVE-Copper miners, Ulta Beauty, gold miners
U.S. STOCKS ON THE MOVE-SciSparc, Paramount, Norfolk Southern
U.S. STOCKS ON THE MOVE-Fisker, Pfizer, Tesla
U.S. STOCKS ON THE MOVE-Biora, Altimmune, crypto stocks
Biora rises after FDA allows human trials for bowel disease treatment
Biora rises as FDA greenlights human trials for bowel disease treatment
Brief: Biora Therapeutics To Submit Updated IND Application For BT-600
Brief: Biora Amends Prospectus Dated Aug 6,2021
U.S. STOCKS ON THE MOVE-Starbucks, Instacart, Dish
U.S. STOCKS ON THE MOVE-Array, Biora, energy firms
Biora rises after top shareholder raises stake with debt exchange deal
Brief: Biora Therapeutics Q2 EPS from cont ops USD -1.47